Trial Profile

A phase 2 clinical trial of STP1

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 04 Oct 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs STP 1 (Primary)
Indications Pervasive child development disorders
Focus Therapeutic Use
Sponsors STALICLA

Most Recent Events

19 Sep 2024 According STALICLA to media release, data readouts from this trial and another Phase 2 trial of STP-2 in Autism spectrum disorders, are expected in next 24 months.
16 Jan 2024 According to STALICLA media release, the company secured 17.4 Million dollars in series B financing that will be used for the preparation of this trial.
19 Jul 2022 According STALICLA to media release, the company plans to initiate this trial in 2023.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com